- FILM-Users - imperial.ac.uk

[FILM-Users 00380] Fwd: Fragment library - sharing of resources within College
by Martin Spitaler 21 Jun '13

21 Jun '13

...forwarded for your information, Martin -------- Original Message -------- Subject: Fragment library - sharing of resources within College Date: Fri, 21 Jun 2013 11:03:35 +0100 From: Rosivatz, Erika <e.rosivatz(a)imperial.ac.uk> To: ICB, All Supervisors <icb-allsupervisors(a)imperial.ac.uk>, Chemistry In the Clinic <citc(a)imperial.ac.uk>, Chapman, Katie L <k.chapman(a)imperial.ac.uk> CC: Tate, Ed W <e.tate(a)imperial.ac.uk>, Cota Segura, Ernesto <e.cota(a)imperial.ac.uk> Dear all, Ernesto Cota and Ed Tate have received funding to expand their 500 compound fragment library to a total 2500 fragments, constituting the full standard Maybridge Ro3 <http://www.maybridge.com/portal/alias__Rainbow/lang__en/tabID__230/DesktopD…> fragment library, plus a library storage system suitable to house it. They would like to know whether the library could complement any existing College libraries or if there is any interest in sharing of resources. To register your interest please complete the questionnaire (link below) by 5^th of July. Feel free to contact Ed or Ernesto (copied) directly for more information. Register your interest now: https://docs.google.com/forms/d/1m5Aa0uPbIY88-xUJMNaXGdjNrEmYIkGAuIZKfkSC9E… Please forward the link to anyone _at Imperial_ who might be interested. Many thanks and best wishes, Erika (ICB) and Emma (LTMR)

1 0

[FILM-Users 00379] Fwd: ESMI PhD AWARD | deadline 30 June
by Martin Spitaler 17 Jun '13

17 Jun '13

...forwarded for your information... Martin -------- Original Message -------- Subject: ESMI PhD AWARD | deadline 30 June Date: Mon, 17 Jun 2013 10:40:17 +0200 From: ESMI <office(a)e-smi.eu> To: <m.spitaler(a)imperial.ac.uk> DearMartin, Dear ESMI members, we would like to invite all young scientists working in the broad field of Molecular Imaging to apply for the *ESMI PhD Award* for excellent PhD thesis. The societies' award for excellent PhD thesis is offered for the purpose of encouraging and rewarding outstanding research conducted by our young members. *Next collection date: 30 June 2013* Read more about the award, eligibility criteria, and how to apply at www.e-smi.eu/index.php?id=2451 <http://www.e-smi.eu/index.php?id=2451> Looking forward to your application and to learn more about your excellent work. Do not hesitate to contact me for any further information. Best regards, Doris /on behalf of the ESMI PhD Award Committee/ Michal Neeman -- Rehovot CHAIR Mathias Hoehn - Cologne Fabian Kiessling - Aachen Chrit Moonen -- Utrecht ** ** *Doris Kracht* ESMI -- European Society for Molecular Imaging** www.e-smi.eu <http://www.e-smi.eu/>__ office(a)e-smi.eu <mailto:office@e-smi.eu>__ phone ++49 221 28206832 fax ++49 221 28206868 Eupener Str. 57-59 50933 Köln *Molecular****Imaging****Meetings****2012*** *2012, April 15-20 **TOPIM * <http://www.topim.eu/>*Processing Biomedical Images Les Houches, France*

1 0

[FILM-Users 00378] Fwd: [1] job on LinkedIn
by Martin Spitaler 17 Jun '13

17 Jun '13

...forwarded for your information, Martin -------- Original Message -------- Subject: [1] job on LinkedIn Date: Sat, 8 Jun 2013 16:53:31 +0000 From: ELMI Group Members <group-digests(a)linkedin.com> To: Martin Spitaler <m.spitaler(a)imperial.ac.uk> ELMI LinkedIn ELMI <http://www.linkedin.com/e/qinvm6-hhp1l6n4-v/vgq/2186621/eml-anet_dig-h_gn-g…> June 8, 2013 Job Discussions (1) *Scientific Officer in the ALMF, EMBL Heidelberg* <http://www.linkedin.com/e/qinvm6-hhp1l6n4-v/ava/247792298/2186621/eml-anet_…> Posted by Stefan Terjung, Scientific Officer at EMBL Like <http://www.linkedin.com/e/csrfyiVJ/qinvm6-hhp1l6n4-v/lvi/2186621/247792298/…> · Flag <http://www.linkedin.com/e/csrfvuDh/qinvm6-hhp1l6n4-v/fav/2186621/247792298/…> Stop inappropriate content the moment it is posted. Send me an email for each new discussion » <http://www.linkedin.com/e/qinvm6-hhp1l6n4-v/snp/2186621/true/eml-anet_dig-b…> You are receiving Group Digest emails. Unsubscribe <https://www.linkedin.com/e/qinvm6-hhp1l6n4-v/z_SqHG4elPRCjWqaHENZBTBWIZcCjN…>. This email was intended for Martin Spitaler (Microscopy Facility Manager at Imperial College London). Learn why we included this <http://www.linkedin.com/e/qinvm6-hhp1l6n4-v/plh/http%3A%2F%2Flinkedin%2Ecus…>. © 2013, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA

1 0

[FILM-Users 00354] Fwd: Re: Merck Millipore CellASIC ONIX Microfluidic Platform
by Martin Spitaler 13 Jun '13

13 Jun '13

Dear microscopists, Brian Robertson has asked us to organise a short demo of the CellASIC ONIX microfluidic system. It's a little microfluidic device which goes on any microscope stage just like a multiwell plate and allows sophisticated controls, perfusion etc. of the sample. See links below for details. Depending on the interest, we thought of organising the demo next Wed / Thu, and if there is interest, one of the days could also be in Hammersmith. Please let us know if you are interested. Good imaging, Martin ------------------------------------------------------------------------ * From:* _donald.innes(a)merckgroup.com_ <mailto:donald.innes@merckgroup.com>[_donald.innes(a)merckgroup.com_ <mailto:donald.innes@merckgroup.com>]* Sent:* 08 May 2013 11:32* To:* Robertson, Brian D* Subject:* Merck Millipore CellASIC ONIX Microfluidic Platform Dear Brian, My name is Donald Innes CellASIC ONIX Sales Specialist for the UK, I believe that you have been in touch with Merck Millipore to request further information on the CellASIC ONIX system? Please find a couple of weblinks to both the Millipore website and the CellASIC site:_ __ __www.millipore.com/cellasic_ <UrlBlockedError.aspx>_ __ __www.cellasic.com/ONIX.html_ <http://www.cellasic.com/ONIX.html> The CellASIC ONIX system uses microfluidic technology to enable continuous live cell imaging with media flow. This propriety technology allows cells to be exposed to different solutions and conditions via pressurised flow channels controlled by user specific time intervals and flow rates. The microfluidic plate can be used with a standard inverted microscope and fits a standard multiwell plate stage. I notice from your research page on the Imperial website that your research is on TB and one aspect is looking at host:pathogen interactions, I have attached an application note with further data: I hope this gives you all the information you require, however please don't hesitate to contact me if you require further information. Best wishes, Donald * Donald Innes* CellASIC ONIX Specialist UK & Ireland Merck Millipore, Bioscience Division Millipore UK Ltd* Mobile: +44 (0)7778 473 754*_ __donald.innes(a)merckgroup.com_ <mailto:donald.innes@merckgroup.com>_ __www.millipore.com_ <http://www.millipore.com/?cid=BIOS-S-ESIG-1052-1302-SP> Merck Millipore is a division of Merck KGaA, Darmstadt, Germany. Text and link to Mandatory Information (in local language) Text and link to Mandatory Information (in English) This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer. [attachment "ATT00002.jpg" deleted by Donald Innes/MIUK/Merck] This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer. [attachment "ATT00004.jpg" deleted by Donald Innes/MIUK/Merck] [attachment "ATT00005.jpg" deleted by Donald Innes/MIUK/Merck] This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer. [attachment "ATT00005.jpg" deleted by Donald Innes/MIUK/Merck] [attachment "ATT00007.jpg" deleted by Donald Innes/MIUK/Merck] [attachment "ATT00008.jpg" deleted by Donald Innes/MIUK/Merck] This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer. This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer.

1 1

[FILM-Users 00375] COMMERCIAL FW: Time's Running Out: Apply Today for EO Grant, takes 8 minutes
by Martin Spitaler 12 Jun '13

12 Jun '13

Edmund Optics Inc. <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> Apply for EO Grant - $80,000 Worldwide <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> Have an Innovative Optics Project? *APPLY & WIN!* If your research is on the cutting-edge of innovation and you haven't received the global recognition you deserve, then you must apply for an EO Higher Education Grant <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…>. We'll introduce you to industry leaders and previous winners. Plus, you could pick out $10,000 worth of free optics, so what are you waiting for? Don't delay, application process takes only 8 minutes! *Hurry, Application Deadline is June 30, 2013!* <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> *Norman Edmund Inspiration Award* The program that embodies the legacy of Edmund Optics' founder, Norman Edmund, will receive $5,000 along with global recognition for their work. Learn more <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> about our 2012 winner, Tomasz Tkaczyk. If you would prefer to not receive emails of this kind, please use the link below. We respect your online time and privacy. TO UNSUBSCRIBE FROM THIS EMAIL NOTIFICATION click here: http://www.photonics.com/Newsletter/EmailUnsubscribe.aspx <http://www.photonics.com/Newsletter/NewsletterLogin.aspx?Email=antonios.kon…> This message was brought to you by Laurin Publishing, 100 West Street, Pittsfield, MA 01201

1 0

[FILM-Users 00373] Fwd: Webinar: The open source microscope concept in theory and practice
by Martin Spitaler 12 Jun '13

12 Jun '13

...forwarded for your information, Martin -------- Original Message -------- Subject: Webinar: The open source microscope concept in theory and practice Date: Mon, 10 Jun 2013 11:15:51 +0200 From: Register for the Olympus Webinar <Olympus_Webinar(a)news.medical-micro.olympus.eu> Reply-To: <re-RB3X0WB-R6T1IW5-WKP5QA(a)news.medical-micro.olympus.eu> To: <m.spitaler(a)imperial.ac.uk> Olympus MSD/MISD Newsletter If this email does not display correctly _click here_ <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-PGLODRH-B7Q4F2.ht…> to view the online version. Olympus Microscopy IX3 series <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R60V11M-MW3196O.h…> Olympus Microscopy IX3 series <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R60V11M-MW3196O.h…> Olympus Microscopy <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-QR11MEP-XB8FK8.ht…> WEBINAR 20 June 2013 Olympus Microscopy IX3 series <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R60V11M-MW3196O.h…> Olympus Microscopy IX3 series <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R60V11M-MW3196O.h…> The open source microscope concept in theory and practice The speed at which life science microscopy applications are currently evolving requires equipment able to match the pace. As the number of tasks required by microscope systems ever-increases, scientists have a real need for equipment flexibility. This webinar in cooperation with _SelectScience <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R8Q31PS-13RR12QQ.…>_ presents a new open source concept to microscopy, which enables microscopists to effortlessly mould their imaging system to wide-ranging application needs. Prof. Sarah Köster, Research Group Leader at the University of Göttingen and Wolfgang Hempell, Section Manager at Olympus Europe, will demonstrate how open source frames can be easily modified for even the most high-end set-ups, such as fluorescence cross-correlation spectroscopy realised on basis of an _IX73_ <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R6T1LDF-SULI5Y.ht…> frame. Key learning objectives: ■ Single wavelength FCCS for in-situ studies of molecular assembly. ■ Infinite light path, the gateway to modify observation methods of microscopes. ■ Open source microscopy, making the infinite light path accessible to every researcher. Register Now <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-R8Q31PS-13RR12QQ.…> IMPRINT OLYMPUS EUROPA HOLDING GMBH Wendestraße 14-18, 20097 Hamburg, Germany, phone: +49 (0)40 23773-0, fax: +49 (0)40 23773-503093 www.olympus-europa.com <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-QR11MEP-XB8FK8.ht…> Commercial Register: Hamburg, No. HRB 10554, VAT registration number: DE 118673662 Management: Stefan Kaufmann (Executive Managing Director), Frank Drewalowski, Arni Ekholm, Matthias Jakob, André Roggan, Yasuo Takeuchi, Nick Williams Chairman of supervisory board: Dr. Joachim Seeler © Olympus 2013 Privacy Notice <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-QFLA05H-12FO13RG.…> Unsubscribe <http://news.medical-micro.olympus.eu/go/0/RB3X0WB-R6T1IW5-NZQ5KUA-45DJ10-U.…>

1 0

[FILM-Users 00371] Fwd: Molecular Medicine & Cell Biology Seminar Series | Tuesday 11 June 2013 | 12:00-13:00 | Room 120, SAF [no event today, 04 June 2013]
by Martin Spitaler 05 Jun '13

05 Jun '13

...forwarded for your information Martin Molecular Medicine & Cell Biology Seminar Series Molecular Medicine | National Heart and Lung Institute & Cell Biology | Division of Medicine Faculty of Medicine | Imperial College London Dr Morgan Beeby Division of Molecular Biosciences, Faculty of Natural Science 'Structural dissection of the bacterial flagellar motor using electron cryo-tomography: insights into function and evolution' Host Pradeep Luther Tuesday 11 June | 12:00-1:00pm Room 120 | Sir Alexander Fleming Building | South Kensington Campus ALL WELCOME -------- Original Message -------- Subject: Molecular Medicine & Cell Biology Seminar Series | Tuesday 11 June 2013 | 12:00-13:00 | Room 120, SAF [no event today, 04 June 2013] Date: Tue, 4 Jun 2013 10:35:24 +0100 From: Enright, Catherine E <c.enright(a)imperial.ac.uk>

1 0

[FILM-Users 00370] COMMERCIAL Fwd: ibidi’s Latest Innovation – Available Soon: µ-Slide 2 well Ph+ and µ-Slide 4 well Ph+
by Martin Spitaler 05 Jun '13

05 Jun '13

-------- Original Message -------- Subject: ibidi’s Latest Innovation – Available Soon: µ-Slide 2 well Ph+ and µ-Slide 4 well Ph+ Date: Tue, 4 Jun 2013 11:33:14 +0200 From: ibidi - cells in focus <events(a)ibidi.de> To: <m.spitaler(a)imperial.ac.uk> Wird diese Nachricht nicht richtig dargestellt, klicken Sie bitte *hier* <http://13457.seu.cleverreach.com/m/6083211/0-c0fcce3f091a29b1c87a7baa3fb125…>. load images * ibidi’s Latest Innovation – /Available Soon/:* *µ-Slide 2 well^Ph+ <http://13457.seu.cleverreach.com/c/11150875/b683f5ae3bd6> and µ-Slide 4 well^Ph+ <http://13457.seu.cleverreach.com/c/11150876/b683f5ae3bd6>* * * *Excellent Phase Contrast Over the Entire Well of the Microscopy Chamber!* * * *Test Now <http://13457.seu.cleverreach.com/c/11150877/b683f5ae3bd6> with Your Experiments!* *Why are these imaging chambers superior?* * *No meniscus at the air-water interface* * *Easy handling and cell culturing* * *High-resolution microscopy through a coverslip-like bottom* * *Excellent cell growth on tissue culture treated surface* *Applications:* * *Cultivation and microscopy of cell cultures* * *High-end fluorescence microscopy* * *Transfection <http://13457.seu.cleverreach.com/c/11150879/b683f5ae3bd6>**assays* * *Live cell imaging <http://13457.seu.cleverreach.com/c/11150880/b683f5ae3bd6>**over extended time periods * Ordering Information: *Cat. No.* *Description* *Pcs./ Box* *µ-Slide 2 well^Ph+ <http://13457.seu.cleverreach.com/c/11150875/b683f5ae3bd6>* 80296 µ-Slide 2 well^Ph+ , ibiTreat, tissue culture treated, sterile 15 80292 µ-Slide 2 well^Ph+ , Collagen IV, sterile 15 80293 µ-Slide 2 well^Ph+ , Fibronectin*, sterile 15 80294 µ-Slide 2 well^Ph+ , Poly-L-Lysine, sterile 15 80295 µ-Slide 2 well^Ph+ , Poly-D-Lysine*, sterile 15 80291 µ-Slide 2 well^Ph+ , hydrophobic, uncoated, sterile 15 *µ-Slide 4 well^Ph+ <http://13457.seu.cleverreach.com/c/11150876/b683f5ae3bd6>* 80446 µ-Slide 4 well^Ph+ , ibiTreat, tissue culture treated, sterile 15 80442 µ-Slide 4 well^Ph+ , Collagen IV, sterile 15 80443 µ-Slide 4 well^Ph+ , Fibronectin*, sterile 15 80444 µ-Slide 4 well^Ph+ , Poly-L-Lysine, sterile 15 80445 µ-Slide 4 well^Ph+ , Poly-D-Lysine*, sterile 15 80441 µ-Slide 4 well^Ph+ , hydrophobic, uncoated, sterile 15 / //*Available only on request./ *Order a FREE SAMPLE <http://13457.seu.cleverreach.com/c/11150877/b683f5ae3bd6> to test ibidi's µ-Slide 2 well^Ph+ and µ-Slide 4 well^Ph+ with your experiments.* Wenn Sie diese E-Mail (an: m.spitaler(a)imperial.ac.uk) nicht mehr empfangen möchten, können Sie diese *hier* <http://13457.seu.cleverreach.com/rmftlp.php?cid=0&mid=6083211&h=0-b683f5ae3…> abbestellen. ibidi GmbH Am Klopferspitz 19 82152 Planegg-Martinsried Deutschland www.ibidi.com events(a)ibidi.de Geschäftsführer: Dr. Roman Zantl, Dr. Valentin Kahl Handelsregister: Amtsgericht München, Registernr.: HRB 135854 Ust.Ident.Nr.: DE 215 296 022 <http://13457.seu.cleverreach.com/c/11150882/b683f5ae3bd6>

1 0

[FILM-Users 00368] Leica Microsystems and Science/AAAS web-seminar on Fluorescent Probes and Digital Imaging
by Martin Spitaler 03 Jun '13

03 Jun '13

...forwarded for your information... Martin -------- Original Message -------- Subject: CONFOCALMICROSCOPY Index - 30 May 2013 to 31 May 2013 (#2013-124) Date: Sat, 1 Jun 2013 00:02:19 -0500 From: CONFOCALMICROSCOPY automatic digest system <LISTSERV(a)LISTS.UMN.EDU> Reply-To: <CONFOCALMICROSCOPY-Search-request(a)LISTS.UMN.EDU> To: <CONFOCALMICROSCOPY(a)LISTS.UMN.EDU> CONFOCALMICROSCOPY Index - 30 May 2013 to 31 May 2013 (#2013-124) CONFOCALMICROSCOPY Index - 30 May 2013 to 31 May 2013 (#2013-124) Index Date Lines Subject and Sender 042272 <http://lists.umn.edu/cgi-bin/wa?A2=ind1305&L=CONFOCALMICROSCOPY&P=R7876> 05/31 96 Free Webinar - Fluorescent Probes and Digital Imaging (commercial posting) From: Lon Nelson <lon.nelson(a)LEICA-MICROSYSTEMS.COM> Browse the CONFOCALMICROSCOPY online archives. <http://lists.umn.edu/cgi-bin/wa?LIST=CONFOCALMICROSCOPY> Powered by the LISTSERV Email List Manager <http://www.lsoft.com/products/listserv-powered.asp> *Registration is required to view this event live or on demand. Please complete the form or login below.* ________________________________________________________________________________________ *Fluorescent Probes and Digital Imaging: Where We Are and Where We're Going* *Event Date: June 12, 2013 12 noon Eastern, 9 a.m. Pacific, 5 p.m. UK, 6 p.m. CEST Brought to you by the Science/AAAS Custom Publishing Office* The discovery of green fluorescent protein a half century ago heralded a new and explosive era in microscopy, forever changing the landscape for biology imaging. The ability to fuse a genetically encoded fluorescent probe to an almost-unlimited variety of proteins has enabled scientists to investigate signaling pathways and the movement of intracellular proteins in living cells with unprecedented detail, particularly when coupled with powerful widefield fluorescence and confocal microscopy techniques. Today, using the expanded selection of probes now available, researchers can even monitor multiple proteins simultaneously, in real time. This webinar will investigate how fluorescent protein probes are currently being utilized for live cell imaging, with a focus on applications in cancer research and where newly developed probes might take us in the near future. During this webinar, our panel of experts will: * Outline the current advances in fluorescent protein probes * Discuss how fluorescent probes are currently being used to image intracellular processes in live cells across a range of cancer research applications * Investigate the potential of new probe technology such as biosensors, photoswitchable probes, and probes emitting in the far-red and infrared portions of the spectrum * Answer your questions live and in real time! *Speakers: * Alan Waggoner, Ph.D. Carnegie Mellon University Pittsburgh, PA W. E. Moerner, Ph.D. Stanford University Stanford, CA Marcel Bruchez, Ph.D. Carnegie Mellon University Pittsburgh, PA -- ------------------------------------------------------------------------ *Martin Spitaler, PhD* *FILM - Facility for Imaging by Light Microscopy* - Facility Manager - Sir Alexander Fleming Building, desk 401 Imperial College London / South Kensington Exhibition Road London SW7 2AZ UK Tel. +44-(0)20-759-42023 E-mail m.spitaler(a)imperial.ac.uk <mailto:m.spitaler@imperial.ac.uk> Website: http://imperial.ac.uk/imagingfacility

1 0

[FILM-Users 00367] Fwd: Fw: MSC webcast. Using microfluidics for real-time imaging of in vitro cell models
by Martin Spitaler 31 May '13

31 May '13

...forwarded for your information, Martin ----- Forwarded by Donald Innes/MIUK/Merck on 28/05/2013 17:45 ----- Original message Nature Publishing Group continues its long standing tradition of providing the means for product manufacturers, service providers, publishers and other corporations to reach members of the scientific community who have opted-in to receive such messages. Nature Publishing Group does not endorse any of the products or services advertised here. To forward this email to a friend, please _click here_ <http://links.ealert.nature.com/servlet/FTFClickServlet?m=41609218&r=NTY2NjA…>. Custom webcast: sponsor retains sole responsibility for content *Using microfluidics for real-time imaging of /in vitro/ cell models** Date: Thursday May 30th 2013** Time: 8am PDT / 11am EDT 4pm BST / 5pm CEST Speakers: Dr Andrew Ball* EMD Millipore * Dr. KC Huang* Stanford University *_ Register for FREE_* <http://links.ealert.nature.com/ctt?kn=4&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS…> Cell cultures, by definition, inhabit the unsteady ground between tight, reproducible experimental control and the ability to simulate the complex and dynamic environments found /in vivo/. This webcast reveals how pioneering microfluidic technology enables the precise manipulation of physiologically relevant micro-environments, helping researchers connect cellular mechanisms with phenotypes and disease states. Microfluidic cell culture chambers allow crucial parameters such as media flow, temperature and gas environment to be automated. This enables researchers to recreate the mass transport environment of tissues, elicit cell responses to dynamic solution changes and enable long-term perfusion culture – a real-time, live cell analysis with unprecedented control. The first speaker, Dr. Andrew Ball, will review a specific workflow involving microfluidic chambers used with a fluorescent microscope and image analysis software, to provide insights for live cell dynamic applications such as host-pathogen interactions, cancer cell autophagy, and cell migration in a standardized format. Then, Dr. KC Huang, will discuss how specific microfluidic techniques have allowed him to study damped oscillations of bacterial growth in response to osmotic shock. Dr. Huang will describe the advantages of real-time, live cell analysis in a microfluidic context. In this webcast you learn: • The advantages and challenges of using microfludic cell culture tools in cell biology • Techniques that can be used to develop and quantify/in vitro/ cell models for predictive cell analysis. *_Register for FREE_* <http://links.ealert.nature.com/ctt?kn=4&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQS…>* **_ _**_View our archived webcasts_* <http://links.ealert.nature.com/ctt?kn=24&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQ…>* * *#MSCwebcasts * Share: _Facebook_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…>_LinkedIn_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…>_Reddit_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…>_StumbleUpon_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…>_Twitter_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…>_Digg_ <http://links.ealert.nature.com/s2s?m=41609218&r=NTY2NjA2NTcyOTQS1&rj=MTg5NT…> As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive third-party emails. If you no longer wish to receive third-party emails from Nature Publishing Group please _update your online account_ <http://links.ealert.nature.com/ctt?kn=15&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQ…>. For further information on _technical assistance_ <mailto:registration@nature.com>| _print subscriptions_ <mailto:subscriptions@nature.com>| _other enquiries_ <mailto:feedback@nature.com>. ------------------------------------------------------------------------ Customer Service Dept. Nature Publishing Group 75 Varick St Fl 9 | New York | NY 10013-1917 | USA <http://links.ealert.nature.com/ctt?kn=21&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQ…> Nature Publishing Group | Principal offices: London | New York and Tokyo, and offices in cities worldwide including Boston | Buenos Aires | Cairo | Delhi | Mumbai | Hong Kong | Madrid | Barcelona | Munich | Heidelberg | Basingstoke | Melbourne | Paris | San Francisco | Seoul and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved. <http://links.ealert.nature.com/ctt?kn=21&ms=NDE2MDkyMTgS1&r=NTY2NjA2NTcyOTQ…> This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click _http://www.merckgroup.com/disclaimer_to access the German, French, Spanish and Portuguese versions of this disclaimer.

1 0